Why the Integrated Research share price rocketed 32% higher today

The Integrated Research Limited (ASX:IRI) share price has rocketed 32% higher today after providing its first half guidance. Here's what you need to know…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

One of the best performers on the Australian share market on Thursday morning has been the Integrated Research Limited (ASX: IRI) share price.

The software company's shares are up a remarkable 32% to $2.19 in early trade following the release of a trading update.

Whilst this is great news for shareholders, it is worth noting that its shares are still down 45% over the last 12 months.

What was in the Integrated Research update?

This morning the company revealed that it is in the early stages of preparing its half year results for the six months ended December 31.

Based on internal management accounts, management expects to report revenue in the range of $49 million to $50.5 million for the half. This represents a 7% to 11% increase on the prior corresponding period.

On the bottom line management anticipates an even stronger result, with profit after tax expected to be in the range of $11.1 million to $11.7 million. This represents 19% to 26% growth on the prior corresponding period.

A key driver of growth for the company was its Licence sales. They are expected to be in the range of $30 million to $31.5 million, representing 17% to 23% growth. This was underpinned by a return to growth from its European operations and a significant contribution from the Payments product line.

What now?

I can't say I'm surprised by the buying frenzy today because things were looking very bleak for the global provider of proactive experience management solutions for critical IT infrastructure, payments and communications ecosystems after a bitterly disappointing FY 2018 and the sudden resignation of its CEO.

But it appears to have rectified things very quickly, making it an interesting option for investors at just 18x estimated FY 2019 earnings.

While I would still choose Altium Limited (ASX: ALU) and Appen Ltd (ASX: APX) ahead of Integrated Research, if it can maintain this level of performance in the second half and into FY 2020 then I expect it to be a very rewarding investment.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Altium and Appen Ltd. The Motley Fool Australia has recommended Integrated Research Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Kingsgate, Neuren, Newcrest, and Pushpay shares are rising today

These ASX shares are avoiding the market selloff on Tuesday.

Read more »

A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs
Share Gainers

Why Neuren, Northern Star, Race Oncology, and Westgold shares are storming higher

These ASX shares are starting the week in a positive fashion.

Read more »

A woman wearing yellow smiles and drinks coffee while on laptop.
Share Gainers

Why APM, Macquarie Telecom, Northern Star, and Origin shares are rising today

These ASX shares are having a strong session despite the market selloff.

Read more »

Two boys with cardboard rockets strapped to their backs, indicating two ASX companies with rocketing share prices
Share Gainers

Catch these fast-rising 2 ASX shares before it's too late: Celeste

This pair of stocks rocketed up in February during reporting season, but are still great value for those willing to…

Read more »

three businessmen high five each other outside an office building with graphic images of graphs and metrics superimposed on the shot.
Share Gainers

Why Arafura, Myer, Volpara, and Xero shares are zooming higher

These ASX shares are making their shareholders smile on Thursday.

Read more »

medical asx share price represented by doctor giving thumbs up
Healthcare Shares

Guess which ASX biotech stock just rocketed 29% on big FDA news

The ASX healthcare share is attracting investor interest following FDA approval for its targeted cancer therapy compound.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Share Gainers

Why Mesoblast, PolyNovo, Pushpay, and Weebit Nano shares are charging higher

These ASX shares are having a strong session despite the market selloff.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why InvoCare, Pentanet, Sayona Mining, and Weebit Nano shares are storming higher

These ASX shares are having a strong session on Tuesday.

Read more »